702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
Main Authors: | Zhonglin Hao, Alberto Chiappori, Adam Schoenfeld, Paul Schwarzenberger, Jacob Sands, Lida Pacaud, Christopher delCorral, Dong Geng, Zhong Yun, Chaun Wang, Gianni Amato, Sahista Vahora |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
7.02 / 10.702 Experimental Biology & Communication, Spring 2005
by: King, Jonathan, et al.
Published: (2023) -
Chimeric Antigen Receptor-T Cell Therapy
by: Jochen Buechner, et al.
Published: (2018-02-01) -
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
by: Kun Ma, et al.
Published: (2023-11-01) -
Chimeric Antigen Receptor beyond CAR-T Cells
by: Vicky Mengfei Qin, et al.
Published: (2021-01-01) -
Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
by: Bryanna Reinhardt, et al.
Published: (2023-02-01)